Xenon Pharmaceuticals Inc.
XENE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$90,896 | -$84,706 | -$65,047 | -$65,685 |
| Dep. & Amort. | $641 | $632 | $659 | $633 |
| Deferred Tax | $0 | -$170 | -$1,213 | -$8,612 |
| Stock-Based Comp. | $13,705 | $13,713 | $12,174 | $13,599 |
| Change in WC | -$269 | $2,623 | -$12,194 | $2,188 |
| Other Non-Cash | $5,067 | $3,675 | $3,969 | $3,492 |
| Operating Cash Flow | -$71,752 | -$64,233 | -$61,652 | -$54,385 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$281 | -$157 | -$43 | -$783 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$88,816 | -$131,239 | -$66,354 |
| Inv. Sales/Matur. | $0 | $171,233 | $165,792 | $165,640 |
| Other Inv. Act. | $38,812 | $0 | $0 | $0 |
| Investing Cash Flow | $38,531 | $82,260 | $34,510 | $98,503 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $87 | $1,151 | $12,083 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,360 | -$22 | $0 | $47 |
| Financing Cash Flow | $2,360 | $65 | $1,151 | $12,130 |
| Forex Effect | -$6 | $632 | -$64 | -$1,157 |
| Net Chg. in Cash | -$30,867 | $18,724 | -$26,055 | $55,091 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $135,381 | $116,657 | $142,712 | $87,621 |
| End Cash | $104,514 | $135,381 | $116,657 | $142,712 |
| Free Cash Flow | -$72,033 | -$64,390 | -$61,695 | -$55,168 |